The idea could be a major win for the health insurance industry, which has seen a crackdown on Medicare Advantage in recent years.

The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply chains, but it could eventually — affecting prices.

In Massachusetts, sepsis cases has more than tripled since 2010. Some blame hospitals' use of AI tools for medical coding and ...

At #STATBreakthrough, top HHS official Chris Klomp talked to STAT about the delicate, high-stakes search for a new CDC ...

The Trump administration is weighing how to respond to a court ruling on vaccine policymaking, a decision that could come ...

STAT interviews with 30 respondents brought the unmistakably human impacts of federal science policy into sharp focus. Here are three of those stories.

Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA ...

In today's Morning Rounds newsletter, the highlights from #STATBreakthrough, a ruling against Kennedy’s gender-affirming care ...

This week on "The Readout LOUD," a conversation with biotech "godfather" Stelios Papadapolous live from #STATBreakthrough.

And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about ...

Following successful appeals from drugmakers, the U.K. is taking another look at whether two new Alzheimer's drugs can be ...

Congress must fix the No Surprises Act before it bankrupts patients and employers, James Gelfand and Patricia Kelmar write.